CRY · GraniteShares YieldBOOST CRCL ETF

-

Please sign in to comment on CRY

1 Comment

Admin

5 years, 1 month ago

CryoLife, Inc is currently in a long term uptrend where the price is trading 15.2% above its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.

CryoLife, Inc's total revenue sank by 2.6% to $68M since the same quarter in the previous year.

Its net income has dropped by 407.8% to $-3M since the same quarter in the previous year.

Finally, its free cash flow grew by 284.0% to $3M since the same quarter in the previous year.

Based on the above factors, CryoLife, Inc gets an overall score of 3/5.

Sector	Healthcare
Industry	Health Care Equipment & Supplies
Exchange	NYSE
CurrencyCode	USD
ISIN	US2289031005

Beta	0.0
Market Cap	703M
PE Ratio	425.71
Target Price	32.44
Dividend Yield	0.2%

ABOUT

GraniteShares YieldBOOST CRCL ETF

The fund will invest at least 80% of its net assets in derivatives contracts that utilize the Underlying Leveraged ETF as their reference asset. It is non-diversified.

CRY · GraniteShares YieldBOOST CRCL ETF

-

GraniteShares YieldBOOST CRCL ETF

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest GraniteShares YieldBOOST CRCL ETF using a moving average strategy